The U.S. Food and Drug Administration (FDA) recently published the draft guidance “Sameness Evaluations in an ANDA – Active Ingredients,” which aims to assist applicants preparing an abbreviated new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback